Neuro-stimulation to control pain during cardioversion defibrillation

• US 5,792,187 A
• Filed: 10/05/1995
• Issued: 08/11/1998
• Est. Priority Date: 02/22/1993
• Status: Expired due to Fees

• Current Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Original Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Inventors: Adams, Theodore P.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): SCHAETZLE, KENNEDY
• Application Number:
  US08/480,938
• Time in Patent Office: 1,041 Days
• Field of Search: 607/2, 607/5, 607/46, 607/47, 607/63, 600/9, 600/13-15, 600/26
• US Class Current: 607/5
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/39624 Pain reduction therapy

Abstract

A system and method for reducing the perceived pain by a patient occurring during cardioversion/defibrillation countershocks to the heart. The system comprises an electrode subsystem for positioning at least one electrode in contact with a patient, a pain reducing stimulation subsystem for providing pain reducing electromagnetic stimulation to the electrode subsystem, a cardioversion/defibrillation countershock subsystem for treatment of cardiac fibrillation, and a control subsystem. The control subsystem provides synchronization of the pain reducing stimulation subsystem with the cardioversion/defibrillation countershock subsystem so that delivery of pain reducing stimulation to the patient begins prior to a cardioversion/defibrillation countershock.

Claims

1. An improved implantable cardioverter defibrillator system, the implantable cardioverter defibrillator system being a self-contained implantable device for implant implanted within a human patient'"'"'s body including a pulse-generating capacitor system that stores a high voltage electrical charge, a battery system that internally charges the pulse-generating capacitor system, and a control system that detects cardiac arrhythmias and, in response, selectively discharges the high voltage electrical charge in the pulse-generating capacitor system through therapy-delivery electrodes implanted within the patient'"'"'s body, the improvement comprising:

a pain-blocking electrode subsystem implanted within the patient'"'"'s body and operably connected to the implantable device and having at least one implantable pain-blocking electrode located adjacent to nerves which are associated with transmitting pain sensations in the patient'"'"'s heart; and

a pain-blocking electrical stimulation system within the implantable device that is electrically connected to the pain-blocking electrode subsystem and the control system and that provides electromagnetic pain nerve blocking stimulation to the at least one implantable pain-blocking electrode in response to detection of a cardiac arrhythmia and prior to discharge of a high voltage electrical charge, the pain nerve blocking stimulation being delivered to the at least one pain-blocking electrode such that nerves proximate the pain-blocking electrode are stimulated so that the patient'"'"'s perception of pain associated with the discharge of the high voltage electrical charge is reduced without altering the patient'"'"'s state of consciousness.

2. The system of claim 1 wherein the at least one implantable pain-blocking electrode is selected from the set consisting of:

a transvenous electrode, a subcutaneous electrode, or any combination thereof.

3. The system of claim 1 wherein the at least one implantable pain-blocking electrode is located proximate nerves which are associated with pain sensations in the patient'"'"'s heart which are selected from the set consisting of:

the vagi nerves, the thoracic dorsal spinal nerves, the sensory cerebrum, or any combination thereof.

4. The system of claim 1 wherein the cardiac arrhythmia which triggers the pain-blocking electrical stimulation system is selected from the set consisting of:

ventricular fibrillation, ventricular tachycardia, atrial fibrillation or atrial tachycardia.